Haemostatic abnormalities in treatment-nave patients with Type 1 Gaucher's disease

Platelets

Volumn 23, Issue 2, 2012, Pages 143-149

  Mitrovic, Mirjana ^a   Antic, Darko ^a   Elezovic, Ivo ^a,b   Janic, Dragana ^b,c   Miljic, Predrag ^a,b   Sumarac, Zorica ^d   Nikolic, Tanja ^d   Suvajdzic, Nada ^a,b  

^a Clinics of Hematology CCS   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c University Children's Hospital   (Serbia)

^d CCS   (Serbia)

Author keywords

bleeding; coagulation; Gaucher's disease; platelet aggregation

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; BLOOD CLOTTING FACTOR; COLLAGEN TYPE 5; VON WILLEBRAND FACTOR;

ACTIVATED PARTIAL TROMBOPLASTIN TIME; ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; BLOOD CELL COUNT; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING PARAMETERS; CHILD; CLINICAL ARTICLE; ENZYME REPLACEMENT; FEMALE; GAUCHER DISEASE; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTHROMBIN TIME; SCHOOL CHILD; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; BLOOD COAGULATION; CHILD; CHILD, PRESCHOOL; ENZYME REPLACEMENT THERAPY; FEMALE; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HEMORRHAGE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET COUNT; SPLEEN; YOUNG ADULT;

EID: 84856838036     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2011.597526     Document Type: Article

References (21)

1. Butler E, Grabowski G. 1995. Gaucher disease. In: Scriver CR, Sly WS, Valle D, editors. The metabolic basis of inherited disease. New York: McGraw-Hill Publishing Company. pp 2641-2670.
2. Berrebi A, Malnick SD, Vorst EJ, Vorst EJ, Stein D. High incidence of factor XI deficiency in Gaucher's disease. Am J Hematol 1992;40:153-161.
3. Humphries JE, Hess CE. Gaucher's disease and acquired coagulopathy. Am J Hematol 1994;45:347-348.
4. Billett HH, Rizvi S, Sawitski A. Coagulation abnormalities in patients with Gaucher's disease: Effect of therapy. Am J Hematol 1996;51:234-236. (Pubitemid 26086371)
5. Hollak CEM, Levi M, Berneds F, Aerts JM, van Oers MH. Coagulation abnormalities in type 1 Gaucher disease are due low-grade activation and can be partly restored by enzyme supplementation therapy. Br J Haematol 1997; 96:470-476. (Pubitemid 27087229)
6. Aerets JMFG, Hollak C. Plasma and metabolic abnormalities in Gaucher disease. Balliere's Clinical Hematology 1997;10:691-707.
7. Gillis S, Hyam E, Abrahamov A, Elstein D, Zimran A. Platelet function abnormalities in Gaucher disease patients. Am J Hematol 1999;61:103-106. (Pubitemid 29252386)
8. Barone R, Giuffrida G, Musso R, Carpinteri G, Fiumara A. Haemostatic abnormalities and lupus anticoagulant activity in patients with Gaucher disease type I. J Inherit Metab Dis 2000;23:387-390. (Pubitemid 30364778)
9. Zimran A, Altarescu G, Rundensky B. Survey of hematolog-ical aspects of Gaucher disease. Hematology 2005;10:151-156. (Pubitemid 41800790)
10. Giona F, Palumbo G, Amendola A, Santoro C, Mazzuconi MG. Platelet function and coagulation abnormalities in type 1 Gaucher disease patients: Effects of enzyme replacement therapy (ERT). J Thromb Haemost 2006;4:1831-1833. (Pubitemid 44144813)
11. Lesić A, Suvajdzić N, Elezović I, Bumbasirevic M, Hadas-Halpern I, Elstein D, Zimran A. Ileopsoas hematoma in Gaucher disease. J Inherit Metab Dis 2006; 29(4):593.
12. Deghady A, Marzouk I, El-Shayeb A, Wali Y. Coagulation abnormalities in type 1 Gaucher disease in children. Ped Hem and Onc 2006;23:411-417. (Pubitemid 44174047)
13. Simchen MJ, Oz R, Shenkman B, Zimran A, Elstein D, Kenet G. Impaired platelet function and peripartum bleeding in women with Gaucher disease. Thromb Haemost 2011;105:509-514.
14. Spectre G, Roth B, Ronen G, Rosengarten D, Elstein D, Zimran A, Varon D, Revel-Vilk S. Platelet adhesion defect in type I Gaucher Disease is associated with a risk of mucosal bleeding. Br J Haematol 2011:Mar 9. doi: 10.1111/j.1365-2141.2011.08613.
15. Kelsey H, Cristopopulos C, Gray AA. Acquired pseudo-pseudo Bernard-Soulier syndrome complicating Gaucher disease. J Clin Pathol 1994;47:162-165. (Pubitemid 24095473)
16. Hoffman R. 2008. Molecular basis of platelet aggregation. In: Hoffman R, editor. Haematology: Basic pronciples and pratice. Philadelphia: Churchill Livingstone an imprint of Elsevier Inc. pp 1320-1437.
17. The British Society for Haematology BCSH Haemostasis and Thrombosis Task Force. Guidelines on platelet function testing. J Clin Pathol 1988;41:1322-1330.
18. Allen MJ, Myer BJ, Khokher AM, Rushton N, Cox TM. Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: Increased release of interleukin-6 and interleukin-10. Quart J Med 1997;90:19-25. (Pubitemid 27075848)
19. Barak V, Acker M, Nisman B, Kalickman I, Abrahamov A, Zimran A, Yatziv S. Cytokines in Gaucher's disease. Eur Cytokine Netw 1999;10:205-210. (Pubitemid 29332776)
20. Hollak CE, Evers L, Aerts JM, van Oers MH. Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease. Blood Cells, Molecules and Diseases 1997; 23:201-212. (Pubitemid 27469455)
21. Jmoudiak M, Futerman AH. Gaucher disease: Pathological mechanisms and modern management. Br J Haematol 2005;129:178-188. (Pubitemid 40562438)